DNAJB9 staining has not been seen in other glomerular diseases including amyloidosis or in healthy subjects, and therefore is a marker for FGN with a reported 100% sensitivity and 100% specificity.[5,9,10]. Here, DNAJB9 is linked to glomerular disorder.